Loading organizations...
Jiuzhou Venture is a venture capital firm based in Jiangsu, China, primarily investing in early-stage companies across the Southeast Asia region. The firm focuses on seed-stage investments across various sectors, with a particular emphasis on technology and semiconductors, targeting innovation-driven companies. While specific portfolio companies or lead investors are not widely publicized, Jiuzhou Venture has demonstrated active deal flow, participating in investment transactions as recently as July 2025. Publicly available information regarding assets under management, valuation, or employee count is not readily available, with most dated public items from 2022 or earlier. The firm's specific founding year and founder names are not definitively stated in public records. Its business model centers on operates as a traditional venture capital firm managing investment funds and making seed-stage investments in portfolio companies.
Jiuzhou Venture has 1 tracked investment across 1 company. The latest tracked deal is $76.7M Series D in Shanghai Cell Therapy Group in March 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 24, 2021 | Shanghai Cell Therapy Group | $76.7M Series D | — | CCB International, Haier Capital |